Condition: Multiple Sclerosis (MS) · Sponsor: University Hospital, Basel, Switzerland
This study is to evaluate the sensitivity and intra-/inter-observer agreement of the averaged magnetization inversion recovery acquisitions (AMIRA) in spinal cord (SC) Multiple sclerosis (MS) lesion detection and to evaluate the additional clinical value of this sequence in clinical settings.
This description comes directly from the study's public registry record.
Katrin Parmar, PD Dr. med. · +41 61 83 65 214 · katrin.parmar@unibas.ch
Charidimos Tsagkas, Dr. med. · charidimos.tsagkas@usb.ch
Always discuss trial participation with your own doctor first.
| University Hospital Basel, Department of Neurology | Basel, Switzerland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04819737